Estimating Covariate-Adjusted Log Hazard Ratios in Randomized Clinical Trials Using Cox Proportional Hazards Models and Nonparametric Randomization Based Analysis of Covariance-Reference-Cited by-同舟云学术

Estimating Covariate-Adjusted Log Hazard Ratios in Randomized Clinical Trials Using Cox Proportional Hazards Models and Nonparametric Randomization Based Analysis of Covariance

Published:2013-02-25 Issue:2 Volume:23 Page:477-490
ISSN:1054-3406
Container-title:Journal of Biopharmaceutical Statistics
language:en
Short-container-title:Journal of Biopharmaceutical Statistics

Author:

Saville Benjamin R.¹,Koch Gary G.²

Affiliation:

1. a Department of Biostatistics , Vanderbilt University School of Medicine , Nashville , Tennessee , USA

2. b Department of Biostatistics , University of North Carolina at Chapel Hill , Chapel Hill , North Carolina , USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/10543406.2012.755692

Reference23 articles.

1. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease

2. On Comparing the Correlations within Two Pairs of Variables

3. U-statistics for skewness or symmetry

4. The role of covariates in estimating treatment effects and risk in long-term clinical trials

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials;BMC Medical Research Methodology;2021-10-17

2. Discussion on “Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes” by David Benkeser, Ivan Diaz, Alex Luedtke, Jodi Segal, Daniel Scharfstein, and Michael Rosenblum;Biometrics;2021-06-09

3. Weighted Empirical and Euclidean Likelihood Covariate Adjustment;Open Statistics;2021-01-01

4. Randomization-Based Adjustment of Treatment Hazard Ratio for Covariates With Missing Data;Statistics in Biopharmaceutical Research;2017-04-03

5. Pirfenidone for the treatment of idiopathic pulmonary fibrosis;Expert Review of Clinical Pharmacology;2017-03-07